Inactive Instrument

Aura Health Inc Share Price Toronto S.E.

Equities

GIR

CA5134413031

Pharmaceuticals

Financials

Sales 2022 - Sales 2023 - Capitalization 4.81M 6.57M 369M
Net income 2022 -8M -10.94M -614M Net income 2023 -13M -17.77M -998M EV / Sales 2022 -
Net Debt 2022 1.09M 1.49M 83.98M Net Debt 2023 1.34M 1.84M 103M EV / Sales 2023 -
P/E ratio 2022
-0.59 x
P/E ratio 2023
-0.24 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 98.99%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 05/09/23
Members of the board TitleAgeSince
Director/Board Member 80 19/12/16
Chairman - 29/08/21
Chief Executive Officer - 05/09/23
More insiders
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.
More about the company